Parallel with the reduction of p-ERK1/2, p-STAT5, and MYC levels, SYK inhibition profoundly decreased clonogenic potential and induced differentiation in AML cell lines (Supplementary Fig. S1C–E). This evidence concerns the gene MAPK3 and acute myeloid leukemia.